Key result
As a study protocol, this paper outlines the planned systematic review and meta-analysis of traditional Chinese medicine for diabetic cardiomyopathy but reports no clinical findings.
Why the study?
No systematic review or meta-analysis had been published on the efficacy and safety of traditional Chinese medicine for treating diabetic cardiomyopathy.
Does traditional Chinese medicine improve clinical efficacy and safety in patients with diabetic cardiomyopathy?
Systematic Review
Does traditional Chinese medicine improve clinical efficacy and safety in patients with diabetic cardiomyopathy?
This protocol outlines a planned systematic review and meta-analysis to evaluate the efficacy and safety of traditional Chinese medicine for diabetic cardiomyopathy.
Protocol for TCM meta-analysis in diabetic cardiomyopathy registered; leaves open clinical recommendations pending synthesized evidence.
BACKGROUND: Diabetic cardiomyopathy, secondary to diabetes, is the main cause of death in patients with diabetes. In China, traditional Chinese medicine has achieved good performance in treating diabetic cardiomyopathy. However, to date, no systematic review or meta-analysis has been published on the treatment of diabetic cardiomyopathy by traditional Chinese medicine. METHODS: This study strictly followed the preferred guidelines for systematic review. Two researchers searched seven databases: EMbase, PubMed, Web of Science, Cochrane Library, China National Knowledge Infrastructure, Chinese Scientific Journal Database, and WANFANG Database. The retrieval time limit ranged from the establishment of the database to August 2022. All clinical randomized controlled trials that met the inclusion and exclusion criteria were included in this study. Statistical analysis was performed using RevMan 5.3. RESULTS: This study analyzed the clinical efficacy and safety of traditional Chinese medicine in the treatment of diabetic cardiomyopathy. CONCLUSION: The results of this study provide evidence-based medical evidence for the clinical use of traditional Chinese medicine in the treatment of diabetic heart disease in the future.
No takes yet. Share an insight, caveat, or question.
Han et al. (2022) conducted a systematic review in Diabetic cardiomyopathy. Traditional Chinese medicine vs. Western medicine treatment was evaluated on Clinical effectiveness rate. As a study protocol, this paper outlines the planned systematic review and meta-analysis of traditional Chinese medicine for diabetic cardiomyopathy but reports no clinical findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: